L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD

Withdrawn before enrolling · Phase 4 · Has a placebo group

Conditions studied: End Stage Renal Disease, Hemodialysis

In brief

Cardiovascular disease is the primary cause of death in patients with end stage renal disease (ESRD). New research suggests that the high risk of death may be partly due to high levels of fibrosis and a loss of small blood vessels in the heart of patients with dialysis-dependent ESRD. This study is designed to compare the effects of two different drugs, spironolactone and L-arginine, with placebo on structure and function of the heart in individuals with dialysis-dependent ESRD.

Key facts

Study ID

NCT01855334

Run by

Brigham and Women's Hospital

People needed

0

Starts

2013-09-01

Expected to finish

2018-07-01

Last updated by the study team

2017-05-04

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Chronic dialysis therapy for End Stage Renal Disease
• Age 21-85

You may not qualify if…

• Hyperkalemia requiring unscheduled dialysis within 3 months
• Pre-dialysis potassium ≥6.5 meq/L within 3 months
• Hypotension defined as SBP <100
• Recurrent intra-dialytic hypotension defined as recurrent cramping, light-headedness, or hypotension requiring infusion of saline or other intervention or otherwise limiting ability to achieve dry weight. Or SBP <80
• History of myocardial infarction
• History of coronary artery bypass surgery
• Non revascularized coronary disease >90%
• Mitral valve repair or replacement
• Severe mitral valve disease
• Renal transplant expected within 9 months
• Expected survival < 9 months
• Pregnant
• Prisoners
• Unable to provide consent
• Allergy to spironolactone or L-arginine
• Digitalis use
• 1st or 2nd degree heart block

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States
• Brigham & Women's Hospital — Boston, Massachusetts, United States
• Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.